+1 (312) 883-8060
Jeff is a partner at Green Griffith. He practices intellectual property law, with an emphasis on counseling, litigation, and opinion matters relating to pharmaceutical, chemical and biochemical products and processes.
Jeff has been active in the Hatch-Waxman field for approximately 30 years. During that time, he has represented pharmaceutical companies and API manufacturers regarding 505(b)(2) and ANDA submissions on a wide variety of products. Jeff has acted as lead counsel and tried numerous Hatch-Waxman litigation matters to verdict. In addition, Jeff has counseled clients regarding filing and regulatory strategies.
Jeff has also litigated patent and trade secret disputes relating to the pharmaceutical, chemical and mechanical arts in various federal courts throughout the United States and in the International Trade Commission, including as lead counsel in a number of jury trials. He also has also led many patent appeals, including arguing those appeals to the U.S. Court of Appeals for the Federal Circuit.
Jeff also has significant experience advising clients with respect to opinion matters, due-diligence issues, patent prosecution strategy, freedom-to-operate opinions, and FDA issues relating to product exclusivities and labeling. Jeff enjoys working closely with his clients to develop creative strategies in line with their business objectives, and then executing those strategies in litigation.
Key Practice Areas:
- IP Office Proceedings
- IP Transactions
- Strategy & Advisory
- Pharmaceuticals inc Biotechnology + Life Sciences
Last updated 17th April 2018